Emerging Role of Mucolipins TRPML Channels in Cancer

Faris, 2018, Endolysosomal Ca(2+) signalling and cancer hallmarks: two-pore channels on the move, TRPML1 lags behind!, Cancers, 11, 27, 10.3390/cancers11010027

Parrington, 2015, Calcium signals regulated by NAADP and two-pore channels–their role in development, differentiation and cancer, Int J Dev Biol, 59, 341, 10.1387/ijdb.150211jp

Nguyen, 2017, Two-pore channel function is crucial for the migration of invasive cancer cells, Cancer Res, 77, 1427, 10.1158/0008-5472.CAN-16-0852

Grimm, 2018, Endolysosomal cation channels and cancer-A link with great potential, Pharmaceuticals, 11, 4, 10.3390/ph11010004

Jung, 2019, HRAS-driven cancer cells are vulnerable to TRPML1 inhibition, EMBO Rep, 20, e46685, 10.15252/embr.201846685

Kasitinon, 2019, TRPML1 promotes protein homeostasis in melanoma cells by negatively regulating MAPK and mTORC1 signaling, Cell Rep, 28, 2293, 10.1016/j.celrep.2019.07.086

Yin, 2019, Downregulated MCOLN1 attenuates the progression of non-small-cell lung cancer by inhibiting lysosome-autophagy, Cancer Manag Res, 11, 8607, 10.2147/CMAR.S216538

Hu, 2019, MCOLN1 promotes proliferation and predicts poor survival of patients with pancreatic ductal adenocarcinoma, Dis Markers, 2019, 9436047, 10.1155/2019/9436047

Xu, 2019, The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways, Cell Calcium, 79, 80, 10.1016/j.ceca.2019.02.010

Liu, 2014, A novel role of transient receptor potential mucolipin1 (TRPML1) in protecting against imidazole-induced cytotoxicity, Biochem Cell Biol, 92, 279, 10.1139/bcb-2014-0044

Morelli, 2019, Transient receptor potential Mucolipin-1 channels in glioblastoma: role in patient's survival, Cancers, 11, 525, 10.3390/cancers11040525

Morelli, 2016, Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression, Oncotarget, 7, 43654, 10.18632/oncotarget.9661

Huang, 2013, Concurrent gene signatures for han chinese breast cancers, PLoS ONE, 8, e76421, 10.1371/journal.pone.0076421

Almamun, 2015, Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia, Epigenetics, 10, 882, 10.1080/15592294.2015.1078050

Wu, 2019, Identification of a nine-gene signature and establishment of a prognostic nomogram predicting overall survival of pancreatic cancer, Front Oncol, 9, 996, 10.3389/fonc.2019.00996

Spix, 2020, TRPML cation channels in inflammation and immunity, Front Immunol, 11, 225, 10.3389/fimmu.2020.00225

Samie, 2009, The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1, Pflugers Arch, 459, 79, 10.1007/s00424-009-0716-5

Bargal, 2000, Identification of the gene causing mucolipidosis type IV, Nat Genet, 26, 118, 10.1038/79095

Sun, 2000, Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel, Hum Mol Genet, 9, 2471, 10.1093/hmg/9.17.2471

Bassi, 2000, Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV, Am J Hum Genet, 67, 1110, 10.1016/S0002-9297(07)62941-3

Cuajungco, 2016, The mucolipin-2 (TRPML2) ion channel: a tissue-specific protein crucial to normal cell function, Pflugers Arch, 468, 177, 10.1007/s00424-015-1732-2

Valadez, 2015, PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene, Gene, 555, 194, 10.1016/j.gene.2014.11.003

Sun, 2015, Novel role of TRPML2 in the regulation of the innate immune response, J Immunol, 195, 4922, 10.4049/jimmunol.1500163

García-Añoveros, 2014, TRPML2 and mucolipin evolution, Handb Exp Pharmacol, 222, 647, 10.1007/978-3-642-54215-2_25

Grimm, 2010, Small molecule activators of TRPML3, Chem Biol, 17, 135, 10.1016/j.chembiol.2009.12.016

DiPalma, 2002, Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice, Proc Natl Acad Sci USA, 99, 14994, 10.1073/pnas.222425399

Grimm, 2007, A helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse, Proc Natl Acad Sci USA, 104, 19583, 10.1073/pnas.0709846104

Xu, 2007, Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice, Proc Natl Acad Sci USA, 104, 18321, 10.1073/pnas.0709096104

Nagata, 2008, The varitint-waddler (Va) deafness mutation in TRPML3 generates constitutive, inward rectifying currents and causes cell degeneration, Proc Natl Acad Sci USA, 105, 353, 10.1073/pnas.0707963105

Noben-Trauth, 2011, The TRPML3 channel: from gene to function, Adv Exp Med Biol, 704, 229, 10.1007/978-94-007-0265-3_13

Morgan, 2011, Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease, Biochem J, 439, 349, 10.1042/BJ20110949

Onyenwoke, 2015, The mucolipidosis IV Ca2+ channel TRPML1 (MCOLN1) is regulated by the TOR kinase, Biochem J, 470, 331, 10.1042/BJ20150219

Zhang, 2016, MCOLN1 is a ROS sensor in lysosomes that regulates autophagy, Nat Commun, 7, 12109, 10.1038/ncomms12109

LaPlante, 2006, Lysosomal exocytosis is impaired in mucolipidosis type IV, Mol Genet Metab, 89, 339, 10.1016/j.ymgme.2006.05.016

Samie, 2013, A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis, Dev Cell, 26, 511, 10.1016/j.devcel.2013.08.003

Cuajungco, 2014, Cellular zinc levels are modulated by TRPML1-TMEM163 interaction, Traffic, 15, 1247, 10.1111/tra.12205

Dong, 2008, The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel, Nature, 455, 992, 10.1038/nature07311

Eichelsdoerfer, 2010, Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel, J Biol Chem, 285, 34304, 10.1074/jbc.C110.165480

Kukic, 2013, Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter, Biochem J, 451, 155, 10.1042/BJ20121506

Kim, 2009, The Ca(2+) channel TRPML3 regulates membrane trafficking and autophagy, Traffic, 10, 1157, 10.1111/j.1600-0854.2009.00924.x

Martina, 2009, The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway, Traffic, 10, 1143, 10.1111/j.1600-0854.2009.00935.x

Chen, 2017, Small molecules for early endosome-specific patch clamping, Cell Chem Biol, 24, 907, 10.1016/j.chembiol.2017.05.025

Plesch, 2018, Selective agonist of TRPML2 reveals direct role in chemokine release from innate immune cells, Elife, 7, e39720, 10.7554/eLife.39720.022

Kim, 2019, Palmitoylation controls trafficking of the intracellular Ca(2+) channel MCOLN3/TRPML3 to regulate autophagy, Autophagy, 15, 327, 10.1080/15548627.2018.1518671

Kondratskyi, 2013, Calcium-permeable ion channels in control of autophagy and cancer, Front Physiol, 4, 272, 10.3389/fphys.2013.00272

Chen, 2014, A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV, Nat Commun, 5, 4681, 10.1038/ncomms5681

Dong, 2010, PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome, Nat Commun, 1, 38, 10.1038/ncomms1037

Shen, 2012, Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release, Nat Commun, 3, 731, 10.1038/ncomms1735

Zhang, 2012, Phosphoinositide isoforms determine compartment-specific ion channel activity, Proc Natl Acad Sci USA, 109, 11384, 10.1073/pnas.1202194109

Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel61727 RaychowdhuryMK González-PerrettS MontalbettiN TimpanaroGA ChasanB GoldmannWH 10.1093/hmg/ddh06714749347Hum Mol Genet132004

Pérez-Riesgo, 2017, Transcriptomic analysis of calcium remodeling in colorectal cancer, Int J Mol Sci, 18, 922, 10.3390/ijms18050922

Zeevi, 2010, Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy, J Cell Sci, 123, 3112, 10.1242/jcs.067330

Guo, 2013, A novel ion channel formed by interaction of TRPML3 with TRPV5, PLoS ONE, 8, e58174, 10.1371/journal.pone.0058174

Cheng, 2010, Mucolipins: intracellular TRPML1-3 channels, FEBS Lett, 584, 2013, 10.1016/j.febslet.2009.12.056

Jung, 2019, TRPML1 and RAS-driven cancers - exploring a link with great therapeutic potential, Channels, 13, 374, 10.1080/19336950.2019.1666457

Puertollano, 2009, TRPMLs: in sickness and in health, Am J Physiol Renal Physiol, 296, F1245, 10.1152/ajprenal.90522.2008

Hou, 2019, Inhibition of PIKfyve using YM201636 suppresses the growth of liver cancer via the induction of autophagy, Oncol Rep, 41, 1971, 10.3892/or.2018.6928

Scotto Rosato, 2019, TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway, Nat Commun, 10, 5630, 10.1038/s41467-019-13572-w

Gayle, 2017, Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma, Blood, 129, 1768, 10.1182/blood-2016-09-736892

Jung, 2019, TRPing the homeostatic alarm - Melanoma cells are selectively vulnerable to TRPML1 deletion, Cell Calcium, 84, 102082, 10.1016/j.ceca.2019.102082

Hodis, 2012, A landscape of driver mutations in melanoma, Cell, 150, 251, 10.1016/j.cell.2012.06.024